Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2018 2
2019 4
2020 4
2021 5
2022 3
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis.
Singh AK, Carroll K, McMurray JJV, Solomon S, Jha V, Johansen KL, Lopes RD, Macdougall IC, Obrador GT, Waikar SS, Wanner C, Wheeler DC, Więcek A, Blackorby A, Cizman B, Cobitz AR, Davies R, DiMino TL, Kler L, Meadowcroft AM, Taft L, Perkovic V; ASCEND-ND Study Group. Singh AK, et al. N Engl J Med. 2021 Dec 16;385(25):2313-2324. doi: 10.1056/NEJMoa2113380. Epub 2021 Nov 5. N Engl J Med. 2021. PMID: 34739196 Clinical Trial.
Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis.
Singh AK, Carroll K, Perkovic V, Solomon S, Jha V, Johansen KL, Lopes RD, Macdougall IC, Obrador GT, Waikar SS, Wanner C, Wheeler DC, Więcek A, Blackorby A, Cizman B, Cobitz AR, Davies R, Dole J, Kler L, Meadowcroft AM, Zhu X, McMurray JJV; ASCEND-D Study Group. Singh AK, et al. N Engl J Med. 2021 Dec 16;385(25):2325-2335. doi: 10.1056/NEJMoa2113379. Epub 2021 Nov 5. N Engl J Med. 2021. PMID: 34739194 Clinical Trial.
Management of acute kidney injury in symptomatic multiple myeloma.
Bridoux F, Leung N, Belmouaz M, Royal V, Ronco P, Nasr SH, Fermand JP; International Kidney and Monoclonal Gammopathy Research Group. Bridoux F, et al. Among authors: belmouaz m. Kidney Int. 2021 Mar;99(3):570-580. doi: 10.1016/j.kint.2020.11.010. Epub 2021 Jan 10. Kidney Int. 2021. PMID: 33440212 Review.
Endocrine disruptors in dialysis therapies: A literature review.
Cambien G, Dupuis A, Guihenneuc J, Bauwens M, Belmouaz M, Ayraud-Thevenot S. Cambien G, et al. Among authors: belmouaz m. Environ Int. 2023 Aug;178:108100. doi: 10.1016/j.envint.2023.108100. Epub 2023 Jul 17. Environ Int. 2023. PMID: 37481953 Free article. Review.
Protein loss and medium cut-off haemodialysis.
Belmouaz M, Bauwens M, Lecron JC, Sibille A, Ecotiere L, Dufour L, Thierry A, Bridoux F. Belmouaz M, et al. Clin Kidney J. 2019 Dec 27;14(1):460-461. doi: 10.1093/ckj/sfz180. eCollection 2021 Jan. Clin Kidney J. 2019. PMID: 33564459 Free PMC article. No abstract available.
Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study.
Joly F, Cohen C, Javaugue V, Bender S, Belmouaz M, Arnulf B, Knebelmann B, Nouvier M, Audard V, Provot F, Gnemmi V, Nochy D, Goujon JM, Jaccard A, Touchard G, Fermand JP, Sirac C, Bridoux F. Joly F, et al. Among authors: belmouaz m. Blood. 2019 Feb 7;133(6):576-587. doi: 10.1182/blood-2018-09-872028. Epub 2018 Dec 21. Blood. 2019. PMID: 30578255 Free article.
17 results